Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Symmetric Anti-HCV Agents: Synthesis, Antiviral Properties, and Conformational Aspects of Core Scaffolds.

Leila ARS, Mousa MHA, Frakolaki E, Vassilaki N, Bartenschlager R, Zoidis G, Abdel-Halim M, Abadi AH.

ACS Omega. 2019 Jul 1;4(7):11440-11454. doi: 10.1021/acsomega.9b01242. eCollection 2019 Jul 31.

2.

Emerging Role of l-Dopa Decarboxylase in Flaviviridae Virus Infections.

Frakolaki E, Kalliampakou KI, Kaimou P, Moraiti M, Kolaitis N, Boleti H, Koskinas J, Vassilacopoulou D, Vassilaki N.

Cells. 2019 Aug 5;8(8). pii: E837. doi: 10.3390/cells8080837.

3.

Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of Flaviviridae viruses and Trypanosoma species.

Giannakopoulou E, Pardali V, Frakolaki E, Siozos V, Myrianthopoulos V, Mikros E, Taylor MC, Kelly JM, Vassilaki N, Zoidis G.

Medchemcomm. 2019 May 16;10(6):991-1006. doi: 10.1039/c9md00200f. eCollection 2019 Jun 1.

PMID:
31303998
4.

L-Dopa decarboxylase interaction with the major signaling regulator ΡΙ3Κ in tissues and cells of neural and peripheral origin.

Vassiliou AG, Siaterli MZ, Frakolaki E, Gkogkosi P, Paspaltsis I, Sklaviadis T, Vassilacopoulou D, Vassilaki N.

Biochimie. 2019 May;160:76-87. doi: 10.1016/j.biochi.2019.02.009. Epub 2019 Feb 20.

PMID:
30796964
5.

The Role of Tissue Oxygen Tension in Dengue Virus Replication.

Frakolaki E, Kaimou P, Moraiti M, Kalliampakou KI, Karampetsou K, Dotsika E, Liakos P, Vassilacopoulou D, Mavromara P, Bartenschlager R, Vassilaki N.

Cells. 2018 Dec 1;7(12). pii: E241. doi: 10.3390/cells7120241.

6.

Expanding the chemical space of anti-HCV NS5A inhibitors by stereochemical exchange and peptidomimetic approaches.

Ramsis TM, Abdel Karim SE, Vassilaki N, Frakolaki E, Kamal AAM, Zoidis G, Ahmed NS, Abadi AH.

Arch Pharm (Weinheim). 2018 Jul;351(7):e1800017. doi: 10.1002/ardp.201800017. Epub 2018 May 25.

PMID:
29799645
7.

Novel nucleoside analogues targeting HCV replication through an NS5A-dependent inhibition mechanism.

Lougiakis N, Frakolaki E, Karmou P, Pouli N, Marakos P, Madan V, Bartenschlager R, Vassilaki N.

Chem Biol Drug Des. 2017 Sep;90(3):352-367. doi: 10.1111/cbdd.12966. Epub 2017 Mar 24.

PMID:
28245093
8.

Virus-host interactions under hypoxia.

Vassilaki N, Frakolaki E.

Microbes Infect. 2017 Mar;19(3):193-203. doi: 10.1016/j.micinf.2016.10.004. Epub 2016 Oct 19. Review.

PMID:
27771294

Supplemental Content

Loading ...
Support Center